Technical Analysis for CRSP - CRISPR Therapeutics AG

Grade Last Price % Change Price Change
B 199.88 -4.84% -10.16
CRSP closed down 4.84 percent on Friday, January 15, 2021, on 2.22 times normal volume. The bulls were able to push the stock to a new 52-week high.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical CRSP trend table...

Date Alert Name Type % Chg
New 52 Week High Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish -4.84%
New 52 Week High Strength -4.84%
Upper Bollinger Band Walk Strength -4.84%
Multiple of Ten Bullish Other -4.84%
Wide Bands Range Expansion -4.84%
Older End-of-Day Signals for CRSP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Trending on StockTwits 1 day ago
60 Minute Opening Range Breakdown 2 days ago
Down 5% 2 days ago
Down 3% 2 days ago
Down 2 % 2 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Acid Immune System Genetics Enzymes Precision Medicine Serious Diseases Genetic Engineering CRISPR Genome Editing Cas9 The Dna

Is CRSP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 220.15
52 Week Low 32.3
Average Volume 1,786,496
200-Day Moving Average 93.71
50-Day Moving Average 142.80
20-Day Moving Average 173.65
10-Day Moving Average 185.37
Average True Range 14.16
ADX 42.75
+DI 38.41
-DI 10.52
Chandelier Exit (Long, 3 ATRs ) 177.66
Chandelier Exit (Short, 3 ATRs ) 186.68
Upper Bollinger Band 209.40
Lower Bollinger Band 137.90
Percent B (%b) 0.87
BandWidth 41.17
MACD Line 16.06
MACD Signal Line 13.89
MACD Histogram 2.165
Fundamentals Value
Market Cap 14.12 Billion
Num Shares 70.7 Million
EPS 0.32
Price-to-Earnings (P/E) Ratio 632.53
Price-to-Sales 92.44
Price-to-Book 5.79
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 231.59
Resistance 3 (R3) 234.82 227.49 226.30
Resistance 2 (R2) 227.49 219.41 225.87 224.54
Resistance 1 (R1) 213.68 214.42 210.02 210.45 222.78
Pivot Point 206.35 206.35 204.51 204.73 206.35
Support 1 (S1) 192.54 198.27 188.88 189.31 176.98
Support 2 (S2) 185.21 193.28 183.59 175.22
Support 3 (S3) 171.40 185.21 173.46
Support 4 (S4) 168.17